GenoMatrix向新西兰商务委员会（NZCC）正式提交了关于Zoetis收购Neogen案件的反垄断意见书。案件编号：PRJ0048995。
Zoetis（硕腾）是全球最大的动物保健公司，Neogen则是动物基因检测领域的重要参与者。此次收购若完成，将在马属基因检测市场形成显著的纵向整合优势。
意见书重点分析了收购完成后可能对独立基因检测实验室的数据获取渠道产生的影响，包括参考数据库访问、技术标准制定和产业链定价等关键环节。
此次提交是GenoMatrix首次在国际反垄断审查中发出独立声音，体现了公司对全球马属基因组学行业健康发展的关注。
GenoMatrix has formally submitted an antitrust opinion to the New Zealand Commerce Commission (NZCC) regarding the Zoetis-Neogen acquisition. Case number: PRJ0048995.
Zoetis is the world's largest animal health company, while Neogen is a significant player in animal genetic testing. If completed, this acquisition would create significant vertical integration advantages in the equine genetic testing market.
The submission focuses on the potential impact on independent genetic testing laboratories' data access channels, including reference database access, technology standard-setting, and supply chain pricing.
This marks GenoMatrix's first independent voice in an international antitrust review, reflecting the company's commitment to the healthy development of the global equine genomics industry.